Top 10 MPO Articles from December

In December, new device launches and online exclusives on M&A activity, 2025 predictions, and the EU Parlement resolution for MDR and IVDR were popular among readers. 

Dexcom launched Stelo CGM, a new GenAI platform. This is the first CGM manufacturer to integrate GenAI into glucose biosensing technology.

Researchers at the Luxembourg Institute of Health developed a voice-based artificial intelligence algorithm to detect Type 2 Diabetes. Using artificial intelligence algorithms, the team achieved a predictive accuracy comparable to the risk score widely used by the American Diabetes Association.

BD and Babson Diagnostics developed a new blood testing process to advance fingertip blood collection and testing technologies for use by U.S. health systems. This less-invasive method can provide results with six drops of capillary blood.

With the rise of AI transformations, Ketryx founder Erez Kaminski makes four predictions about what trends will drive the medtech industry in 2025. 

The European Parliament recently adopted a resolution to revise key elements of the Medical Devices Regulation (MDR) and In Vitro Diagnostic Devices Regulation (IVDR). It intends to address ongoing challenges ahead of the 2025 implementation deadline. The resolution seeks to improve patient access to critical medical products while streamlining regulatory processes.

1. Dexcom Rolls Out GenAI Platform for Stelo CGM
2. Studies Show Staggering Economic Burden of Heart Failure
3. What the EU Parliament’s Resolution Means for MDR and IVDR
4. New AI Tool Identifies Diabetes Using Voice Analysis
5. Four Bold Predictions for Medtech in 2025: AI Everywhere, Faster Releases, and Rising Risks
6. Merit Medical President Joe Wright Resigns
7. J&J MedTech Joins Efforts to Define, Classify Surgical Site Outcomes
8. 2024 Medical Device Manufacturing M&A Roundup
9. BD, Babson Diagnostics Launches Fingertip Blood Testing to Health Care Organizations
10. Data-Driven Manufacturing in the Medical Device Sector